Abstracts tagged "Quality of care and systemic lupus erythematosus (SLE)"

Abstract Number: 1399 • 2016 ACR/ARHP Annual Meeting
Transitioning Lupus Patients from Pediatric to Adult Rheumatology
Joyce Hui-Yuen¹, Ashlea Cook², Lisa F. Imundo³, Amy Starr², Andrew Eichenfield⁴ and Anca D. Askanase⁵, ¹North Shore-Long Island Jewish Health System, Lake Success, NY, ²Pediatric Rheumatology, Columbia University Medical Center, New York, NY, ³Assoociate Professor of Pediatrics in Medicine - Rheumatology, Columbia University Medical Center, New York, NY, ⁴Morgan Stanley Children's Hospital of NY-Presbyterian, Columbia University, New York, NY, ⁵Department of Medicine, Rheumatology, Columbia University College of Physicians & Surgeons, New York, NY
Background/Purpose: Pediatric rheumatologists have successfully improved the life expectancy and quality of life of children with systemic lupus (cSLE). cSLE has higher morbidity and mortality…
Abstract Number: 2041 • 2016 ACR/ARHP Annual Meeting
Validity and Reliability of Patient Reported Outcomes Measurement Information System (PROMIS®) Global Health Short Form in Patients with SLE
Shanthini Kasturi¹, Jayme C. Burket², Jessica Berman¹, Kyriakos A. Kirou¹, Alana B. Levine¹, Lisa R. Sammaritano¹ and Lisa Mandl¹, ¹Rheumatology, Hospital for Special Surgery, New York, NY, ²Healthcare Research Institute, Hospital for Special Surgery, New York, NY
Background/Purpose: The measurement of patient reported outcomes (PROs) is a growing priority for performance improvement in clinical care of chronic conditions such as SLE. Measuring…
Abstract Number: 784 • 2015 ACR/ARHP Annual Meeting
Electronic Health Record (EHR) As a Powerful Tool to Establish Clinical Research Lupus Cohorts
Srilatha Kothandaraman¹, Frederick Ramsey², David Fleece³, Aaron Sorenson², Lai Ping⁴, Srikanth Mukkera¹, King Goh¹ and Roberto Caricchio⁵, ¹Rheumatology, Temple University, Philadelphia, PA, ²Clinical Sciences, Temple University, Philadelphia, PA, ³Pediatrics, Temple University, Philadelphia, PA, ⁴Temple University, Philadelphia, PA, ⁵Medicine, Rheumatology, Temple University, Philadelphia, PA
Background/Purpose: Enhancing a typical EHR through implementation and utilization of research-validated instruments is termed Electronic Data Capture (EDC). EDC is found to be more efficient…
Abstract Number: 1912 • 2013 ACR/ARHP Annual Meeting
Do Persons With SLE In Poverty Rate Interactions With Providers and Health Plans Differently?
Edward H. Yelin¹, Chris Tonner², Laura Trupin² and Jinoos Yazdany³, ¹Medicine, UC San Francisco, San Francisco, CA, ²Medicine, University of California, San Francisco, San Francisco, CA, ³Rheumatology, University of California, San Francisco, San Francisco, CA
Background/Purpose: We previously showed that poverty is associated with the quantity, type, and technical quality of care in SLE.[1] Here we assess whether poverty is…
Abstract Number: 2600 • 2012 ACR/ARHP Annual Meeting
Assessment of Quality of Care for Incident Lupus Nephritis in the U.S. Medicaid Population
Jinoos Yazdany¹, Candace H. Feldman², Jun Liu³, Michael M. Ward⁴, Michael A. Fischer⁵ and Karen H. Costenbader⁶, ¹Medicine, University of California, San Francisco, San Francisco, CA, ²Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ³Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, Boston, MA, ⁴Bldg 10 CRC Rm 4-1339, NIAMS/NIH, Bethesda, MD, ⁵Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA, ⁶Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
Background/Purpose: The contribution of uneven health care quality to racial/ethnic and socioeconomic disparities in lupus nephritis outcomes is unknown. We aimed to assess performance on…
Abstract Number: 2057 • 2012 ACR/ARHP Annual Meeting
Analysis of the Adherence to the Monitoring of Glucocorticoid Eye Toxicity and of the Prevalence of Cataracts and Glaucoma Among Patients with Systemic Lupus Erythematosus
Linda Carli¹, Chiari Tani¹, Francesca Querci², Alessandra Della Rossa¹, Sabrina Vagnani³, Anna d'Ascanio⁴, Rossella Neri⁵, Antonio Tavoni⁶, Stefano Bombardieri³ and Marta Mosca¹, ¹Internal Medicine, Rheumatology Unit, Department of Internal Medicine, University of Pisa, PISA, Italy, ²Rheumatology Unit, University of Pisa, Pisa, Italy, ³Department of Internal Medicine, Rheumatology Unit, Department of Internal Medicine, University of Pisa, PISA, Italy, ⁴Department of Internal Medicine, University of Pisa, Rheumatology Unit, Department of Internal Medicine, University of Pisa, PISA, Italy, ⁵University of Pisa, Rheumatology Unit, Pisa, Italy, ⁶Dept of Internal Medicine, Immunoallergology Unit, Department of Internal Meicine, University of Pisa, PISA, Italy
Background/Purpose: Cataracts and glaucoma are among the main causes of impaired visual acuity and have a prevalence respectively of 9-17% and 1-2% among subjects older…
Abstract Number: 2040 • 2012 ACR/ARHP Annual Meeting
Provisions of Quality Driven Care in Childhood-Onset Systemic Lupus Erythematosus
Matthew C. Hollander¹, Jessica M. Sage², Alexandria J. Greenler², Tadej Avcin³, Michael W. Beresford⁴, Graciela Espada⁵, Marisa S. Klein-Gitelman⁶, Michael Henrickson⁷, Tsz-Leung Lee⁸, Joshua D. Pendl⁹, Marilynn G. Punaro¹⁰, Jennifer L. Huggins¹¹, Anne M. Stevens¹² and Hermine Brunner¹¹, ¹Division of Rheumatology, Seattle Children's Hospital, Seattle, WA, ²Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ³International Investigator Consortium for MAS Diagnostic Criteria, Ljubljana, Slovenia, ⁴Paediatric Rheumatology, Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom, ⁵Rheumatology Section, Childrens Hosp Ricardo Gutierrez, Buenos Aires, Argentina, ⁶Division of Rheumatology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, ⁷MLC 4010, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁸Paediatrics and Adolescent Med, Queen Mary Hospital, Hong Kong, Hong Kong, ⁹Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ¹⁰Pediatric Rheumatology, Texas Scottish Rite Hospital, Dallas, TX, ¹¹Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ¹²Pediatrics, University of Washington, Seattle, WA
Background/Purpose: Quality Indicators (QI) are retrospectively measurable elements of practice performance for which there is evidence or consensus that can be used to assess the…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].